Post-extubation stridor in Respiratory Syncytial Virus bronchiolitis: Is there a role for prophylactic dexamethasone?

Esther S Veldhoen1, Charlotte A Smulders1, Teus H Kappen2

  • 1Department of Pediatric Intensive Care, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

Plos One
|February 17, 2017
PubMed

Insights

Reintubation due to airway obstruction is a risk for infants with Respiratory Syncytial Virus bronchiolitis. Prophylactic dexamethasone before extubation may significantly lower this reintubation risk.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neonatology
  • Respiratory Medicine

Background:

  • Respiratory Syncytial Virus (RSV) bronchiolitis is a common cause of respiratory insufficiency in infants.
  • Invasive mechanical ventilation is often required for severe cases.
  • Upper airway obstruction and reintubation are potential complications post-extubation.

Purpose of the Study:

  • To determine the incidence of reintubation due to upper airway obstruction in infants with RSV bronchiolitis.
  • To investigate the association between prophylactic dexamethasone and the risk of reintubation.

Main Methods:

  • Retrospective observational study in two Dutch Pediatric Intensive Care Units.
  • Included 200 infants (<13 months) with RSV bronchiolitis requiring mechanical ventilation.
  • Logistic regression with propensity score analysis was used to control for confounding factors.

Main Results:

  • The incidence of reintubation due to post-extubation stridor was 8.5% (17/200 patients).
  • Prophylactic dexamethasone administration prior to extubation was significantly associated with a reduced risk of reintubation (p=0.0011).
  • An absolute risk reduction of 13% (95% CI 5.3-21%) was observed in the dexamethasone group.

Conclusions:

  • Post-extubation stridor necessitating reintubation is a significant complication in ventilated infants with RSV bronchiolitis.
  • Prophylactic dexamethasone prior to extubation likely reduces the risk of reintubation.
  • Further placebo-controlled trials are warranted to confirm the efficacy of prophylactic dexamethasone.
Abstract

Related Concept Videos

Endotracheal Tube Extubation01:24

Endotracheal Tube Extubation

Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
5.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
572
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1000